AroCell AB (publ) reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was SEK 6.35 million compared to SEK 0.03 million a year ago. Net loss was SEK 15.9 million compared to SEK 6.73 million a year ago. Basic loss per share from continuing operations was SEK 0.07 compared to SEK 0.09 a year ago. Diluted loss per share from continuing operations was SEK 0.07 compared to SEK 0.09 a year ago.
For the six months, sales was SEK 14.12 million compared to SEK 0.073 million a year ago. Net loss was SEK 31.38 million compared to SEK 12.81 million a year ago. Basic loss per share from continuing operations was SEK 0.16 compared to SEK 0.17 a year ago. Diluted loss per share from continuing operations was SEK 0.16 compared to SEK 0.17 a year ago.